| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3452 |
| Trial ID | NCT05871684 |
| Disease | Diffuse Large B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | Regent CAR-T 001 cells |
| Co-treatment | BTKi and/or PD-1 inhibitor |
| Phase | Phase2 |
| Recruitment status | Not Recruiting |
| Title | A Combination Study of CAR-T Therapy in r/r B-NHL |
| Year | 2023 |
| Country | China |
| Company sponsor | Ruijin Hospital |
| Other ID(s) | CAR-T 001 |
| Cohort 1 | |||||||
|
|||||||